JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Onychomatricoma: benign sporadic nail lesion or much more?

Onychomatricomas (OM) are rare subungual tumors first described just over a decade ago. Surprisingly, these lesions still rarely are reported in the literature. This may be because of a lack of awareness, understanding, or interest in these perceivably benign lesions. In this review, we discuss the current literature and understanding of OM. We attempt to ascertain predilections and patterns in an attempt to establish a stronger appreciation of OM, and to encourage future reports. We emphasize the importance of reporting such lesions; with a larger literature base, prevalence, etiology, and pathogenesis can be better determined.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app